Mircea Ivan
- Cancer Research top 0.05%
- Cancer, Hypoxia, and Metabolism 27
- MicroRNA in disease regulation 26
- Cancer-related molecular mechanisms research 18
- Molecular Biology top 0.5%
- RNA modifications and cancer 19
- Epigenetics and DNA Methylation 10
- Circular RNAs in diseases 10
- RNA Research and Splicing 7
- Ubiquitin and proteasome pathways 5
- Biochemistry top 1%
- Genetics top 1%
- Oncology top 2%
Mircea Ivan
78 papers receiving 11.8k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Cancer Research 8.3k
- Molecular Biology 8.3k
- Biochemistry 441
- Genetics 1.4k
- Oncology 1.3k
Countries citing papers authored by Mircea Ivan
This map shows the geographic impact of Mircea Ivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mircea Ivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mircea Ivan more than expected).
Fields of papers citing papers by Mircea Ivan
This network shows the impact of papers produced by Mircea Ivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mircea Ivan. The network helps show where Mircea Ivan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mircea Ivan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The EGLN-HIF O 2 -Sensing System: Multiple Inputs and Feedbacksbreakdown → | 2017 | 198 |
| 2 | The role of MicroRNA molecules and MicroRNA-regulating machinery in the pathogenesis and progression of epithelial ovarian cancer | 2017 | 2 |
| 3 | 2016 | 93 | |
| 4 | Enhancing Hematopoietic Stem Cell Transplantation Efficacy by Mitigating Oxygen Shock | 2015 | 0 |
| 5 | 2015 | 238 | |
| 6 | Gene Expression Analysis Reveals Distinct Pathways of Resistance to Bevacizumab in Xenograft Models of Human ER-Positive Breast Cancer | 2014 | 2 |
| 7 | Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER. : Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER. | 2014 | 1 |
| 8 | 2014 | 10 | |
| 9 | 2013 | 92 | |
| 10 | 2012 | 27 | |
| 11 | Targeting the insulin growth factor and the vascular endothelial growth factor pathways in ovarian cancer | 2012 | 1 |
| 12 | 2011 | 99 | |
| 13 | 2011 | 39 | |
| 14 | MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU | 2010 | 1 |
| 15 | 2009 | 363 | |
| 16 | 2009 | 237 | |
| 17 | 2008 | 218 | |
| 18 | A MicroRNA Signature of Hypoxiabreakdown → | 2006 | 890 |
| 19 | HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensingbreakdown → | 2001 | 3874 |
| 20 | 1997 | 30 |
About Mircea Ivan
Mircea Ivan is a scholar working on Cancer Research, Molecular Biology and Genetics, having authored 80 papers that have together received 11.9k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (27 papers), MicroRNA in disease regulation (26 papers), RNA modifications and cancer (19 papers), Cancer-related molecular mechanisms research (18 papers), Epigenetics and DNA Methylation (10 papers), Circular RNAs in diseases (10 papers), RNA Research and Splicing (7 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Cancer Research (8.3k citations), Molecular Biology (8.3k citations) and Biochemistry (441 citations). Mircea Ivan has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include William G. Kaelin, Haifeng Yang, Michael Ohh, Keiichi Kondo, William S. Lane, William Kim, Adrian Salic, John M. Asara, Ritu Kulshreshtha and Nikola P. Pavletich. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research, Molecular Cancer Therapeutics, Oncogene and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.